Skip to content

Efficacy and outcomes of dapagliflozin in diabetic nephropathy: A systematic review and meta-analysis.

Meta-analysis · Medicine (Baltimore) · 2025. Source record refreshed; an explanation has not been reviewed.

Meta-analysisSource: PubMed · PMID 40629621

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Efficacy and outcomes of dapagliflozin in diabetic nephropathy: A systematic review and meta-analysis.

Dahal K, Rawal L, Shah S et al.
Medicine (Baltimore) · 2025

PubMed ID
40629621
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.